Synergistic clinical efficacy of niraparib in combination with pembrolizumab in patients with recurrent platinum-resistant ovarian carcinoma
Ann Transl Med
.
2019 Dec;7(Suppl 8):S308.
doi: 10.21037/atm.2019.10.28.
Authors
Joan Tymon-Rosario
1
,
Burak Zeybek
1
,
Chanhee Han
1
,
Alessandro D Santin
1
Affiliation
1
Department of Obstetrics, Gynecology, and Reproductive Sciences, Co-Chief Gynecologic Oncology, Yale University School of Medicine, New Haven, CT, USA.
PMID:
32016027
PMCID:
PMC6976388
DOI:
10.21037/atm.2019.10.28
No abstract available
Publication types
Editorial
Comment
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States